Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Translational PediatricsOpen Access

Real-world experience of thrombopoietin receptor agonists in pediatric immune thrombocytopenia: a report from a Chinese tertiary children’s hospital

View Full Paper
Ask AI
Bookmark
Share

Authors

JFJunjie FanYangtze UniversityJCJing ChenNorth China University of Science and TechnologyLGLi GaoQingdao University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fan et al. (2024) studied this question.

synapsesocial.com/papers/68e66dd2b6db6435875f92d8https://doi.org/10.21037/tp-24-48
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1American Society of Hematology 2019 guidelines for immune thrombocytopenia2019 · 1,422 citations
  2. 2Immune Thrombocytopenia Associated with Mycoplasma pneumoniae Infection2018 · 18 citations
  3. 3International consensus report on the investigation and management of primary immune thrombocytopenia2009 · 2,284 citations
  4. 4Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia2021 · 57 citations
  5. 5Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study2016 · 95 citations